Alexandra M. Levine MD

Professor of Medicine, USC School of Medicine

1500 Duarte RdNeedleman #213Duarte, CA 91010
Phone+1 626-471-7213
Fax+1 626-471-7200

Dr. Levine is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levine's full profile Already have an account?

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1976 - 1977
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1974 - 1975
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1971 - 1974
Keck School of Medicine of the University of Southern CaliforniaClass of 1971

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1972 - 2027
HI State Medical License 1983 - 2020
GA State Medical License 1974 - 1987

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017
CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017
CMS Meaningful Use Stage 2 Certification Sunrise Ambulatory Care, Allscripts, 2013-2017

Clinical Trials

Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
TERMINATED
PHASE2
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
WITHDRAWN
PHASE2

Publications & Presentations

PubMed

11 citations
Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.
Anna L. Hotton, Kathleen M. Weber, Ronald C. Hershow, Kathryn Anastos, Peter Bacchetti
Journal of Acquired Immune Deficiency Syndromes. 2017-06-01
41 citations
“The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV
Tonya N. Taylor, Corrine Munoz-Plaza, Lakshmi Goparaju, Omar Martinez, Susan Holman
Archives of Sexual Behavior. 2017-05-01
16 citations
Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy.
David B. Hanna, Molly Jung, Xiaonan Xue, Kathryn Anastos, Jennifer Cocohoba
AIDS Patient Care and Stds. 2016-10-01

Lectures

6th Annual Conference On How The Experts Treat Hematologic Malignancies
City of Hope, Santa Monica, California - 9/18/2013

Press Mentions

City of Hope Appoints Leading Lung Cancer Expert Dr. Christine M. Lovly to Head National Thoracic Oncology ProgramNovember 6th, 2025
Renowned Breast Cancer Physician-Scientist Hope S. Rugo, M.D., to Lead City of Hope’s Women’s Cancers ProgramApril 17th, 2025
Researchers Develop Test Using Machine Learning to Help Predict Immunotherapy Response in Lymphoma PatientsApril 1st, 2025

Grant Support

Southern California Women'S Interagency HIV Study ConsortiumEunice Kennedy Shriver National Institute Of Child Health &Human Development2008
A Phase I Study Of VEGF- Antisense Oligonucleotide (Vegf-As) Given As A DailyNational Center For Research Resources2007–2008
A Randomized Phase II Trial Of Epoch (AIDS)National Center For Research Resources2005–2008
Women'S Interagency HIV StudyEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
University Of Southern CaliforniaNational Cancer Institute2006